Australia is like every developed market where governments are engaged in "constant work" to evolve their funding systems to ensure patient access to the latest medical technologies, according to Harout Semerjian, executive vice president and chief commercial officer of Ipsen.
Latest Video
New Stories
-
Vinnies named inaugural partner of Pharmacy Guild Foundation
August 18, 2026 - -
Opportunity #2 - AI can democratise HTA and the negotiations must not squander it
August 18, 2026 - - Latest News -
Opportunity #1 - biosimilar policy failure has become impossible to ignore
August 18, 2026 - -
Mesoblast completes treatment in pivotal low back pain trial as phase 3 readout approaches
August 17, 2026 - - Australian Biotech -
Dimerix takes control of US development pathway for new kidney injury treatment
August 17, 2026 - - Australian Biotech -
OncoSil secures FDA approval for targeted bile duct cancer device
August 17, 2026 - - Latest News -
Has any patient ever said they accept a rejection because of the Kaplan-Meier curve?
August 17, 2026 - - Latest News

